<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:947dd697-2deb-4533-a37c-b9dcdf3d3c1e,g:562a5470-aff2-437c-87f4-5193be27726a,d:29f3cb40453540779d0c3c038a4be08d--><html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cvs-20200915</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF80L2ZyYWc6ZjY1ZjI2YTg5YzM3NGViMmEwNDRiZDQyNGFjYzgzMzMvdGFibGU6NTgwYjllZmQyMTdhNDU2Y2IzYjgwNzlkMTQyY2Q3NTMvdGFibGVyYW5nZTo1ODBiOWVmZDIxN2E0NTZjYjNiODA3OWQxNDJjZDc1M18yLTEtMS0xLTA_095475a3-02ca-48b9-99bd-da8e7805e146">0000064803</ix:nonNumeric><ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF80L2ZyYWc6ZjY1ZjI2YTg5YzM3NGViMmEwNDRiZDQyNGFjYzgzMzMvdGFibGU6NTgwYjllZmQyMTdhNDU2Y2IzYjgwNzlkMTQyY2Q3NTMvdGFibGVyYW5nZTo1ODBiOWVmZDIxN2E0NTZjYjNiODA3OWQxNDJjZDc1M18zLTEtMS0xLTA_aa3b9659-51bf-4613-807c-fca251f0a367">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cvs-20200915.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-15</xbrli:startDate><xbrli:endDate>2020-09-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i29f3cb40453540779d0c3c038a4be08d_1"></div><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%;">UNITED STATES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">Washington, D.C. 20549</span></div><div><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%;">FORM <ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGV4dHJlZ2lvbjo5ODU2YmQ0YTk2MDg0ZjMxYTQ3ZjYxODBhYWEyMGI2YV8xMzg2_494095d0-512a-4e61-9cfc-a121f330e41e">8-K</ix:nonNumeric> </span></div><div><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">CURRENT REPORT</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</span></div><div><span><br/></span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%;"><tr><td style="width:1.0%;"></td><td style="width:71.773%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:26.027%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Date of Report (Date of earliest event reported):</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGFibGU6Mjg1ZjFmODMwMjI4NDRjYWJhNjY2NzJkNjEzYTEyYmQvdGFibGVyYW5nZToyODVmMWY4MzAyMjg0NGNhYmE2NjY3MmQ2MTNhMTJiZF8wLTEtMS0xLTA_e2897daf-16b2-4e7d-bee0-bed243283b2c">September 15, 2020</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center;"><img src="cvs-20200915_g1.jpg" alt="cvs-20200915_g1.jpg" style="height:20px;width:112px;"/></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGV4dHJlZ2lvbjo5ODU2YmQ0YTk2MDg0ZjMxYTQ3ZjYxODBhYWEyMGI2YV8xMzkw_75e03a22-7fa6-4580-a0a6-6e1e7d47b55c">CVS HEALTH CORP</ix:nonNumeric>ORATION</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:32.233%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:32.233%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:32.234%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGFibGU6MTIxN2Q3NThkZDEzNDllMWJiMjNhYWZlYmYzOWJkN2QvdGFibGVyYW5nZToxMjE3ZDc1OGRkMTM0OWUxYmIyM2FhZmViZjM5YmQ3ZF8wLTAtMS0xLTA_419e61e7-8273-409c-bcf3-165c3c593c76">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGFibGU6MTIxN2Q3NThkZDEzNDllMWJiMjNhYWZlYmYzOWJkN2QvdGFibGVyYW5nZToxMjE3ZDc1OGRkMTM0OWUxYmIyM2FhZmViZjM5YmQ3ZF8wLTEtMS0xLTA_eeac33d7-6f8e-4160-8eef-28825cbf3da5">001-01011</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGFibGU6MTIxN2Q3NThkZDEzNDllMWJiMjNhYWZlYmYzOWJkN2QvdGFibGVyYW5nZToxMjE3ZDc1OGRkMTM0OWUxYmIyM2FhZmViZjM5YmQ3ZF8wLTItMS0xLTA_c544af8c-e628-495c-bb75-8b8ac5aa9413">05-0494040</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Commission <br/>File Number)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(IRS Employer <br/>Identification No.)</span></td></tr><tr><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGV4dHJlZ2lvbjo5ODU2YmQ0YTk2MDg0ZjMxYTQ3ZjYxODBhYWEyMGI2YV8xMzg3_64b506b2-e282-47e4-8698-4bb1df71c702">One CVS Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGV4dHJlZ2lvbjo5ODU2YmQ0YTk2MDg0ZjMxYTQ3ZjYxODBhYWEyMGI2YV8xMzgw_fa96b65d-1788-4bd6-9e61-8f46e31a24f6">Woonsocket</ix:nonNumeric>, <ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGV4dHJlZ2lvbjo5ODU2YmQ0YTk2MDg0ZjMxYTQ3ZjYxODBhYWEyMGI2YV8xMzgx_597c7614-9149-4107-904d-a3e6c3b69579">Rhode Island</ix:nonNumeric>&#160;&#160;<ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGV4dHJlZ2lvbjo5ODU2YmQ0YTk2MDg0ZjMxYTQ3ZjYxODBhYWEyMGI2YV8xMzkx_59030b54-34b0-4489-916e-851b91f68367">02895</ix:nonNumeric> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Address of principal executive offices)&#160;&#160;&#160;(Zip Code)</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Registrant&#8217;s telephone number, including area code: &#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(<ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGV4dHJlZ2lvbjo5ODU2YmQ0YTk2MDg0ZjMxYTQ3ZjYxODBhYWEyMGI2YV8xMzgy_88a023ec-1bd8-4847-beb1-48ce5be33fc1">401</ix:nonNumeric>) <ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGV4dHJlZ2lvbjo5ODU2YmQ0YTk2MDg0ZjMxYTQ3ZjYxODBhYWEyMGI2YV8xMzgz_87158aa9-61d9-4a85-b00e-78c64704fcf9">765-1500</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Former name or former address, if changed since last report:&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">N/A</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGV4dHJlZ2lvbjo5ODU2YmQ0YTk2MDg0ZjMxYTQ3ZjYxODBhYWEyMGI2YV8xMzg4_a4e968b0-e4fe-436b-93b0-7490cf72727a">&#9744;</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGV4dHJlZ2lvbjo5ODU2YmQ0YTk2MDg0ZjMxYTQ3ZjYxODBhYWEyMGI2YV8xMzg5_32f662ab-f11a-4099-9e19-2dcdadd6bc42">&#9744;</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGV4dHJlZ2lvbjo5ODU2YmQ0YTk2MDg0ZjMxYTQ3ZjYxODBhYWEyMGI2YV8xMzg0_254162aa-92f5-42db-9755-6f11f07fc2e7">&#9744;</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGV4dHJlZ2lvbjo5ODU2YmQ0YTk2MDg0ZjMxYTQ3ZjYxODBhYWEyMGI2YV8xMzg1_0e795d0f-8769-45cd-a370-c1bbe9448fd6">&#9744;</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%;"><tr><td style="width:1.0%;"></td><td style="width:33.759%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:18.545%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:44.396%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Title of each class</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trading Symbol(s)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGFibGU6MmIxMjU5YWI0ZGM3NDQyZTkyYWM2MDBkMGI1NTgwNjEvdGFibGVyYW5nZToyYjEyNTlhYjRkYzc0NDJlOTJhYzYwMGQwYjU1ODA2MV8xLTAtMS0xLTA_ca6de8dc-cab4-4d6a-bf67-e6d01576d6f5">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGFibGU6MmIxMjU5YWI0ZGM3NDQyZTkyYWM2MDBkMGI1NTgwNjEvdGFibGVyYW5nZToyYjEyNTlhYjRkYzc0NDJlOTJhYzYwMGQwYjU1ODA2MV8xLTEtMS0xLTA_b3de184b-a927-493a-a290-41f849823da3">CVS</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGFibGU6MmIxMjU5YWI0ZGM3NDQyZTkyYWM2MDBkMGI1NTgwNjEvdGFibGVyYW5nZToyYjEyNTlhYjRkYzc0NDJlOTJhYzYwMGQwYjU1ODA2MV8xLTItMS0xLTA_2a2d82cf-0ead-42b5-b3da-a929414919ca">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:96.707%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.993%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Emerging growth company</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.8pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="icc328fb06f9c4d0ba719dc7d951cb855_D20200915-20200915" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjI5ZjNjYjQwNDUzNTQwNzc5ZDBjM2MwMzhhNGJlMDhkL3NlYzoyOWYzY2I0MDQ1MzU0MDc3OWQwYzNjMDM4YTRiZTA4ZF8xL2ZyYWc6OTg1NmJkNGE5NjA4NGYzMWE0N2Y2MTgwYWFhMjBiNmEvdGFibGU6ZTdiM2VmZWJkYmUwNGZmYzk4NGQ2ODliOGE3Yjc4MTYvdGFibGVyYW5nZTplN2IzZWZlYmRiZTA0ZmZjOTg0ZDY4OWI4YTdiNzgxNl8wLTEtMS0xLTA_181c94b6-bca1-4571-b7d1-f6cba8999dfa">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:justify;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.8pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9744;</span></td></tr></table></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><div id="i29f3cb40453540779d0c3c038a4be08d_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Section 7 - Regulation FD</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 7.01   Regulation FD Disclosure.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Members of CVS Health Corporation&#8217;s (the &#8220;Company&#8217;s&#8221;) senior management team are scheduled to meet with investors during the remainder of September 2020. While continuing to acknowledge the inherent and unprecedented uncertainty surrounding the ongoing coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic and its impact, the senior management team will discuss a revision to the Company's full year 2020 GAAP diluted earnings per share (&#8220;EPS&#8221;) guidance range to $5.16 to $5.29 from $5.59 to $5.72, reflecting the estimated loss on early extinguishment of debt during the third quarter of 2020. The senior management team will also discuss that the Company will maintain its previously announced full year 2020 Adjusted EPS </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> guidance range of $7.14 to $7.27 and its full year 2020 cash flow from operations guidance range of $11.0 billion to $11.5 billion.</span></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(1)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;">GAAP diluted EPS and Adjusted EPS, respectively, are calculated by dividing net income attributable to CVS Health (GAAP measure) and adjusted income attributable to CVS Health by the Company&#8217;s weighted average diluted shares outstanding. The Company defines adjusted income attributable to CVS Health as net income attributable to CVS Health excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance, such as acquisition-related integration costs, losses on early extinguishment of debt, gains/losses on divestitures, the corresponding income tax benefit or expense related to the items excluded from adjusted income attributable to CVS Health, and any other items specifically identified herein. The following table reconciles projected GAAP diluted EPS to projected Adjusted EPS:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:70.537%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.384%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.496%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.384%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.499%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ending December 31, 2020</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Low</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">High</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Projected GAAP diluted EPS (GAAP measure)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.16</span><span style="font-size:10pt;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.29</span><span style="font-size:10pt;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-GAAP adjustments (per share):</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.76</span><span style="font-size:10pt;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.76</span><span style="font-size:10pt;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisition-related integration costs</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.34</span><span style="font-size:10pt;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.34</span><span style="font-size:10pt;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loss on early extinguishment of debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.58</span><span style="font-size:10pt;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.58</span><span style="font-size:10pt;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain on divestiture of subsidiary</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.17)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.17)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.53)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.53)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Projected Adjusted EPS</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.14</span><span style="font-size:10pt;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.27</span><span style="font-size:10pt;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Weighted average diluted shares outstanding </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;">(in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,320</span><span style="font-size:10pt;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,320</span><span style="font-size:10pt;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company uses non-GAAP financial measures to analyze underlying business performance and trends. The Company believes that providing these non-GAAP financial measures enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance. These non-GAAP financial measures are provided as supplemental information to the financial measures that are calculated and presented in accordance with GAAP. Non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. The Company&#8217;s definitions of its non-GAAP financial measures may not be comparable to similarly titled measures reported by other companies.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cautionary Statement Concerning Forward-Looking Statements</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. Statements in this Current Report on Form 8-K that are forward-looking include CVS Health&#8217;s full year 2020 per share projections for net income attributable to CVS Health, adjusted income attributable to CVS Health, amortization of intangible assets, acquisition-related integration costs, losses on early extinguishment of debt, gains/losses on divestitures, and the income tax benefit related to items excluded from adjusted income attributable to CVS Health, as well as full year 2020 cash flow from operations and the weighted average diluted shares outstanding for the year ending December 31, 2020. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to the risks and uncertainties related to the COVID-19 pandemic, the </span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">geographies impacted and the severity and duration of the pandemic, the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns, and the timing, scope and impact of stimulus legislation and other federal, state and local governmental responses to the pandemic, as well as the risks and uncertainties described in our Securities and Exchange Commission (&#8220;SEC&#8221;) filings, including those set forth in the Risk Factors section and under the heading &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; in the Company&#8217;s most recently filed Annual Report on Form 10-K and its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">You are cautioned not to place undue reliance on CVS Health&#8217;s forward looking statements. CVS Health&#8217;s forward-looking statements are and will be based upon management&#8217;s then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Section 9 - Financial Statements and Exhibits</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 9.01   Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">Exhibits</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The exhibits to this Current Report on Form 8-K are as follows: </span></div><div><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">INDEX TO EXHIBITS</span></div><div><span><br/></span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%;"><tr><td style="width:1.0%;"></td><td style="width:4.911%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.111%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:84.678%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.</span></td></tr></table></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">SIGNATURES</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"></td><td style="width:46.777%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:3.145%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:46.778%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CVS HEALTH CORPORATION</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Date: September 15, 2020</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">By:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Eva C. Boratto</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Eva C. Boratto</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "cvs-20200915.htm", "description": "8-K", "secsgml_size_bytes": 64557}]
{"company-data": {"conformed-name": "CVS HEALTH Corp", "cik": "0000064803", "assigned-sic": "5912", "irs-number": "050494040", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-01011", "film-number": "201174660"}, "business-address": {"street1": "ONE CVS DR.", "city": "WOONSOCKET", "state": "RI", "zip": "02895", "phone": "4017651500"}, "mail-address": {"street1": "ONE CVS DR.", "city": "WOONSOCKET", "state": "RI", "zip": "02895"}, "former-company": [{"former-conformed-name": "CVS CAREMARK CORP", "date-changed": "20070509"}, {"former-conformed-name": "CVS/CAREMARK CORP", "date-changed": "20070322"}, {"former-conformed-name": "CVS CORP", "date-changed": "19970128"}]}
cvs-20200915
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
September 15, 2020
CVS HEALTH CORP
ORATION
(Exact name of registrant as specified in its charter)
Delaware
001-01011
05-0494040
(State or other jurisdiction of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
One CVS Drive
,
Woonsocket
,
Rhode Island
02895
(Address of principal executive offices)   (Zip Code)
Registrant's telephone number, including area code:
(
401
)
765-1500
Former name or former address, if changed since last report:
N/A
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
CVS
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Section 7 - Regulation FD
Item 7.01   Regulation FD Disclosure.
Members of CVS Health Corporation's (the "Company's") senior management team are scheduled to meet with investors during the remainder of September 2020. While continuing to acknowledge the inherent and unprecedented uncertainty surrounding the ongoing coronavirus disease 2019 ("COVID-19") pandemic and its impact, the senior management team will discuss a revision to the Company's full year 2020 GAAP diluted earnings per share ("EPS") guidance range to $5.16 to $5.29 from $5.59 to $5.72, reflecting the estimated loss on early extinguishment of debt during the third quarter of 2020. The senior management team will also discuss that the Company will maintain its previously announced full year 2020 Adjusted EPS
(1)
guidance range of $7.14 to $7.27 and its full year 2020 cash flow from operations guidance range of $11.0 billion to $11.5 billion.
(1)
GAAP diluted EPS and Adjusted EPS, respectively, are calculated by dividing net income attributable to CVS Health (GAAP measure) and adjusted income attributable to CVS Health by the Company's weighted average diluted shares outstanding. The Company defines adjusted income attributable to CVS Health as net income attributable to CVS Health excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company's business nor reflect the Company's underlying business performance, such as acquisition-related integration costs, losses on early extinguishment of debt, gains/losses on divestitures, the corresponding income tax benefit or expense related to the items excluded from adjusted income attributable to CVS Health, and any other items specifically identified herein. The following table reconciles projected GAAP diluted EPS to projected Adjusted EPS:
Year Ending December 31, 2020
Low
High
Projected GAAP diluted EPS (GAAP measure)
$
5.16
$
5.29
Non-GAAP adjustments (per share):
Amortization of intangible assets
1.76
1.76
Acquisition-related integration costs
0.34
0.34
Loss on early extinguishment of debt
0.58
0.58
Gain on divestiture of subsidiary
(0.17)
(0.17)
Income tax benefit
(0.53)
(0.53)
Projected Adjusted EPS
$
7.14
$
7.27
Weighted average diluted shares outstanding
(in millions)
1,320
1,320
The Company uses non-GAAP financial measures to analyze underlying business performance and trends. The Company believes that providing these non-GAAP financial measures enhances the Company's and investors' ability to compare the Company's past financial performance with its current performance. These non-GAAP financial measures are provided as supplemental information to the financial measures that are calculated and presented in accordance with GAAP. Non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. The Company's definitions of its non-GAAP financial measures may not be comparable to similarly titled measures reported by other companies.
Cautionary Statement Concerning Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. Statements in this Current Report on Form 8-K that are forward-looking include CVS Health's full year 2020 per share projections for net income attributable to CVS Health, adjusted income attributable to CVS Health, amortization of intangible assets, acquisition-related integration costs, losses on early extinguishment of debt, gains/losses on divestitures, and the income tax benefit related to items excluded from adjusted income attributable to CVS Health, as well as full year 2020 cash flow from operations and the weighted average diluted shares outstanding for the year ending December 31, 2020. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to the risks and uncertainties related to the COVID-19 pandemic, the
geographies impacted and the severity and duration of the pandemic, the pandemic's impact on the U.S. and global economies and consumer behavior and health care utilization patterns, and the timing, scope and impact of stimulus legislation and other federal, state and local governmental responses to the pandemic, as well as the risks and uncertainties described in our Securities and Exchange Commission ("SEC") filings, including those set forth in the Risk Factors section and under the heading "Cautionary Statement Concerning Forward-Looking Statements" in the Company's most recently filed Annual Report on Form 10-K and its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2020.
You are cautioned not to place undue reliance on CVS Health's forward looking statements. CVS Health's forward-looking statements are and will be based upon management's then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.
Section 9 - Financial Statements and Exhibits
Item 9.01   Financial Statements and Exhibits.
(d)
Exhibits
.
The exhibits to this Current Report on Form 8-K are as follows:
INDEX TO EXHIBITS
104
Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CVS HEALTH CORPORATION
Date: September 15, 2020
By:
/s/ Eva C. Boratto
Eva C. Boratto
Executive Vice President and Chief Financial Officer